𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Characterization of Human Monoclonal Antibodies Specific to the Hepatitis C Virus Glycoprotein E2 within VitroBinding Neutralization Properties

✍ Scribed by François Habersetzer; Anne Fournillier; Jean Dubuisson; Domenico Rosa; Sergio Abrignani; Czeslaw Wychowski; Isao Nakano; Christian Trépo; Claude Desgranges; Geneviève Inchauspé

Book ID
112272021
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
399 KB
Volume
249
Category
Article
ISSN
0042-6822

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human monoclonal antibodies that react w
Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity
✍ Darren J. Schofield; Birke Bartosch; Yohko K. Shimizu; Tobias Allander; Harvey J 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Active and/or passive immunoprophylaxis against hepatitis C virus (HCV) remain unachieved goals. Monoclonal antibodies might provide one approach to protection. We derived human monoclonal antibodies from the bone marrow of a patient with a well-controlled HCV infection of 22 years duration. Five di

Characterization of the hepatitis C viru
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33
✍ Alexander W. Tarr; Ania M. Owsianka; Judith M. Timms; C. Patrick McClure; Richar 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 680 KB

The mouse monoclonal antibody (MAb) AP33, recognizing a 12 amino acid linear epitope in the hepatitis C virus (HCV) E2 glycoprotein, potently neutralizes retroviral pseudoparticles (HCVpp) carrying genetically diverse HCV envelope glycoproteins. Consequently, this antibody and its epitope are highly